60 Degrees Pharmaceuticals, Inc. (SXTP) Stock Statistics & Valuation Metrics

60 Degrees Pharmaceuticals, Inc. has a market cap or net worth of $3.39M. The enterprise value is $165.07K.

60 Degrees Pharmaceuticals, Inc. has 1,472,891 shares outstanding. The number of shares has decreased by -2.65% in one year.

60 Degrees Pharmaceuticals, Inc.’s return on equity (ROE) is -1.97 and return on invested capital (ROIC) is -236.33%.

The current PE Ratio of 60 Degrees Pharmaceuticals, Inc. is -0.37. 60 Degrees Pharmaceuticals, Inc.’s PEG ratio is <0.01.

In the last 12 months, 60 Degrees Pharmaceuticals, Inc. had revenue of 607.57K and earned -7.95M in profits. Earnings per share was -18.55.

In the last 12 months, operating cash flow was -6.11M and capital expenditures -176.78K, giving a free cash flow of -6.28M billion.

60 Degrees Pharmaceuticals, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

60 Degrees Pharmaceuticals, Inc. upcoming earnings date is Aug 13, 2025, During Market Hours (Confirmed).

60 Degrees Pharmaceuticals, Inc. as a current ratio of 3.25, with Debt / Equity ratio of 3.78%

In the past 12 months, 60 Degrees Pharmaceuticals, Inc. has paid 250.00 in taxes.

60 Degrees Pharmaceuticals, Inc. EV to EBITDA ratio is -0.18, with an EV/FCF ratio of -0.25.

60 Degrees Pharmaceuticals, Inc. has $3.45M in cash and marketable securities with $155.27K in debt, giving a net cash position of -$3.30M billion.

Gross margin is 40.10%, with operating margin of -1598.97%, and net profit margin of -1308.01%.

The average price target for 60 Degrees Pharmaceuticals, Inc. is $7.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy